Transcat (TRNS) Earnings Analysis
Transcat (TRNS) has no confirmed upcoming earnings date. Last quarter (2026-05-26) it beat with EPS 0.56 USD vs 0.51 USD est (+9.8%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 124.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TRNS next report earnings?
No confirmed upcoming earnings date is currently scheduled for TRNS. This page updates as the calendar is published.
TRNS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-26 | 0.56 USD | 0.51 USD | +9.8% | Beat |
| 2025-11-03 | 0.14 USD | 0.4175 USD | -66.5% | Miss |
| 2025-05-19 | 0.64 USD | 0.66 USD | -3% | Miss |
| 2025-01-27 | 0.45 USD | 0.38 USD | +18.4% | Beat |
| 2024-10-28 | 0.35 USD | 0.46 USD | -23.9% | Miss |
| 2024-07-28 | 0.48 USD | 0.36 USD | +33.3% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
TRNS valuation and analyst view
| Trailing P/E | 124.04 |
|---|---|
| Trailing EPS | 0.70401 USD |
| Price / book | 2.74 |
| Dividend yield | 0.00% |
| Market cap | 0.82B |
| Analyst consensus | Buy (8 buy / 2 hold / 0 sell) |
| Avg price target | 95 USD |
Related research pages
Frequently asked questions
When is Transcat (TRNS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for TRNS. This page updates as the calendar is published.
Did TRNS beat earnings last quarter?
In its 2026-05-26 report, TRNS posted EPS of 0.56 USD versus a 0.51 USD estimate — a beat of 9.8%.
What is TRNS's earnings track record?
Over the last 6 reported quarters with consensus data, TRNS beat estimates 3 times (50%).
What is TRNS's current P/E ratio and EPS?
TRNS trades at a trailing P/E of 124.04 on trailing EPS of 0.7040128410914928 USD.
What do analysts rate TRNS?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 95 USD.